Directorate Change
January 20 2004 - 2:00AM
UK Regulatory
RNS Number:4100U
Bespak PLC
20 January 2004
For Immediate Release 20 January 2004
Bespak plc
Appoints new Chairman to the Board
Bespak plc (LSE: BPK), an innovator in drug delivery, is today pleased to
announce with immediate effect the appointment of John Robinson, ex-Smith &
Nephew, as the new Chairman of the Company.
Sir David Cooksey, who has served as Chairman of Bespak for the past eight years
and as a director for ten years, has stepped down from the Board today.
Sir David will be replaced by John Robinson, who from 1990 to 1997 was Chief
Executive of Smith & Nephew, the largest medical technology company in the UK.
John was subsequently Chairman of Smith & Nephew until 2000.
He is currently Chairman of George Wimpey, Chairman of Paragon Healthcare Group
and Chairman and Pro-Chancellor of the University of Hull. Previously he has
held positions at companies that include ICI, Fisons and Railtrack Group.
Mark Throdahl, Chief Executive of Bespak, commented:
"Over the past few years Bespak has been transformed from a manufacturing to a
technology-led business. Sir David has been instrumental in this
transformation, particularly through his emphasis on R&D investment.
"I am delighted to welcome John Robinson as Chairman and am extremely pleased
that we can attract a medical technology leader of his stature to Bespak. He
will bring management strength and outstanding industry experience to our
Company."
For further information please call:
Bespak plc
Mark Throdahl - Chief Executive On 20.01.04: +44 (0) 20 7466 5000
Thereafter: +44 (0) 20 1908 552 600
Buchanan Communications +44 (0) 20 7466 5000
Tim Thompson/Mark Court/ Mary-Jane Johnson
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAGUUGCGUPCGBB